Omnicell

Market context

Hospital automation is a practical robotics-adjacent market: medication movement, pharmacy workflows and inventory control can be automated before broader clinical robotics arrives.

Facts

• Website: https://www.omnicell.com
• HQ: Fort Worth, Texas, US
• Founded: 1992
• Ticker: OMCL / NASDAQ
• Segment: Healthcare

Omnicell role in healthcare robotics

Omnicell supplies medication-management automation, pharmacy robotics, dispensing cabinets and inventory systems for healthcare providers. Hospital automation is a practical robotics-adjacent market: medication movement, pharmacy workflows and inventory control can be automated before broader clinical robotics arrives.

• Target environment: Hospitals, surgical centers, rehabilitation settings, pharmacy operations, care providers and medical-device workflows.
• Deployment model: Healthcare robotics model built around devices, enabling technology, procedure support, care workflows or clinical automation.
• Customer context: Medical-device companies, hospitals, surgeons, care providers, rehabilitation teams, pharmacy operators and healthcare buyers.
• Workflow context: Procedure support, rehabilitation, care delivery, pharmacy automation, hospital logistics, clinical data capture and device-assisted workflows.
• Commercial maturity: Published company profile with public sources supporting its robotics-adjacent role; deployment depth varies by product line and customer evidence.
• Market position: Healthcare robotics and medical-automation participant with relevance to procedure, care or device workflows.
• Adoption constraints: Adoption depends on clinical validation, safety, workflow integration, regulatory clearance, purchasing cycles and service support.
• Adjacent context: Surgical robotics, rehabilitation robots, hospital automation, pharmacy automation, clinical devices and assistive technology.
• Source confidence: medium

Events

• 2024-04-16 - Product Launch - Omnicell announces XT Amplify innovation program for automated dispensing systems - Omnicell announced XT Amplify as a multi-year innovation program for its XT Automated Dispensing System installed base. The program includes solutions such as XTExtend and MedChill for pharmacy and point-of-care medication workflows. The launch extends Omnice…
• 2015-10-29 - Acquisition - Omnicell agrees to acquire Aesynt for $275M - Deal value: $275 million Acquired portfolio included automated dispensing, central pharmacy robotics and IV robotics Transaction expanded Omnicell from medication automation into a broader pharmacy robotics platform

Team

• Randall Lipps - Chairman, President, Chief Executive Officer and Founder - His role covers Omnicell's pharmacy automation, dispensing and medication-management systems.
• Virad Gupta - Senior Vice President, Chief Technology Officer - The CTO role is directly relevant to Omnicell's automation platform and healthcare workflow software.